Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.380
-0.200 (-4.37%)
At close: Oct 5, 2026, 4:00 PM EDT
4.452
+0.072 (1.63%)
After-hours: Oct 5, 2026, 7:55 PM EDT
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $364.4 million as of October 5, 2026. Its market cap has increased by 207.44% in one year.
Market Cap
364.40M
Enterprise Value
311.79M
1-Year Change
207.44%
Ranking
Category
Stock Price
$4.38
ChartMarket Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $364.40M, an increase of 1,613.80%. That is a compound annual growth rate of 61.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 364.40M | 162.88% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 397.07M |
| Eikon Therapeutics | 397.03M |
| Zura Bio | 393.86M |
| Galectin Therapeutics | 393.31M |
| Kyverna Therapeutics | 384.67M |
| Relmada Therapeutics | 384.01M |
| vTv Therapeutics | 379.83M |
| Prelude Therapeutics | 377.99M |